CPHI China | Showcasing Cutting-Edge Innovations in Sodium Hyaluronate and Pharmaceutical Ingredients
Release time:
2024-06-26
Last week, the Freda Pharma Group team had the pleasure of attending CPHI China, one of the leading pharmaceutical events in the region. This is an exciting opportunity for us to showcase our latest advances in sodium hyaluronate and other pharmaceutical products.


At this event, we are proud to showcase our latest CEP certified medical grade sodium hyaluronate. Our main ingredients includes eye drop grade, injection grade and medical device grade. Eye drops grade HA is carefully developed to meet the highest quality and safety standards, including GMP certification.


In addition to our flagship sodium hyaluronate product, we have launched our newest ingredients including Zinc Hyaluronate, 800 rejuv and 15D Sodium Hyaluronate. This is an important milestone for Freda Pharma Group as it is the first time that we collectively participate in such a prestigious event.
At FocusFreda, we are also committed to providing comprehensive OEM one-stop manufacturing services for health food supplements, providing various specifications and formulas that comply with international standards.


Mingren Freda focuses on promoting safe and healthy plant extracts for health food production and cosmetics manufacturing, drawing on the rich heritage of traditional Chinese medicine science to promote the integrated development of cosmetics, medicines and food.


One of our core products, Ectoin developed by Freda Biotech, has successfully passed the US FDA's API DMF registration, achieving an important milestone. This achievement makes it one of only two products of its kind in the world to receive this recognition, reflecting our unwavering commitment to excellence and regulatory compliance.



Relying on the strong scientific research strength of the Institute of Pharmacy, Haiyou Freda provides a variety of API raw materials such as gliclazide, fenphenylacetate, and oxybuvacaine, all of which have obtained GMP certification. In addition, our raw materials such as tadalafil have obtained CEP certification, highlighting our determination to provide high-quality pharmaceutical ingredients to domestic and foreign customers.

The Freda team is full of passion and enthusiasm and we thoroughly enjoyed the face-to-face interactions with our esteemed clients during the event. We believe that this direct communication is not only efficient, but also rich, allowing us to gain valuable insights and make meaningful connections.
We extend our sincere wishes to all visitors to the CPHI China booth and we will continue to be committed to providing first-class pharmaceutical solutions to meet the changing needs of the industry.



BLOGS
See You in Paris! Focusfreda Brings the "HA+" to in-cosmetics Global 2026
Join Focusfreda at in-cosmetics Global 2026 (Booth 2S59) in Paris. Discover our "HA+" philosophy and new biotech breakthroughs: Copper Lysinate Hyaluronate and Lysine Hyaluronate for sustainable, high-performance skincare.
Discover why the combination of Sodium Polyglutamate (Gamma-PGA) and Hyaluronic Acid (HA) is the new gold standard in professional skincare. Explore the science of the 3D Moisture Matrix and Focusfreda’s green bio-fermentation technology.
Explore the synergistic benefits of oral Sodium Hyaluronate and Ergothioneine (EGT). Learn how EGT stabilizes HA via the OCTN1 transporter to prevent oxidative degradation, enhancing bioavailability in next-generation longevity dietary supplements for 2026.
Good Breakthrough | FocusFreda Secures First NCI Registration for "Lysine Hyaluronate"
FocusFreda achieves a skincare milestone with the China NMPA registration of Lysine Hyaluronate (NCI No. 20260026). This innovative "Hyaluronic Acid+" ingredient combines essential amino acid for superior skin affinity, enzymatic stability, and synergistic repair. Explore how FocusFreda is leading the global shift toward high-end, science-backed green beauty solutions.
Knee osteoarthritis (KOA) is a common chronic joint disease with an increasing prevalence among older adults, severely impacting quality of life. Sodium hyaluronate (SH), as a core component of synovial fluid, is a key drug in KOA treatment. However, different molecular weights of SH exhibit significant differences in efficacy and mechanism of action, directly affecting treatment options. This article focuses on interpreting its differentiating effects to provide a reference for clinical application. [Reference Interpretation: Figure 1]
Is Hyaluronic Acid Ingredient Good for Acne? Safe Hydration for Breakout-Prone Skin
Learn whether hyaluronic acid is good for acne-prone skin, if it clogs pores, how it supports the skin barrier, and how to pair it with retinoids, niacinamide, and BHA—plus routine tips and FAQs.